New trial study on G3 patients Nov 15, 2015 9:29:33 GMT Quote Select PostDeselect PostLink to PostMemberGive GiftBack to Top Post by Admin on Nov 15, 2015 9:29:33 GMT Seems that combining Sof, Dac & Riba and extending to 16 weeks greatly improves chances for G3s with significant fibrosis/cirrhosis:www.hcplive.com/conference-coverage/aasld-2015/hepatitis-c-an-effective-regimen-for-genotype-3